METiS TechBio’s $270M Hong Kong IPO Shows Growing Momentum for AI‑Driven Drug Delivery | Answer

METiS TechBio’s $270M Hong Kong IPO Shows Growing Momentum for AI‑Driven Drug Delivery | Answer | Studio Global